T. Rowe Price Associates
BMY icon

T. Rowe Price Associates’s Bristol-Myers Squibb BMY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$337M Buy
7,273,615
+1,484,239
+26% +$68.7M 0.04% 323
2025
Q1
$353M Sell
5,789,376
-1,738,535
-23% -$106M 0.04% 319
2024
Q4
$426M Sell
7,527,911
-12,711,872
-63% -$719M 0.05% 294
2024
Q3
$1.05B Buy
20,239,783
+4,939,412
+32% +$256M 0.12% 162
2024
Q2
$635M Buy
15,300,371
+2,752,548
+22% +$114M 0.08% 224
2024
Q1
$680M Buy
12,547,823
+5,461,767
+77% +$296M 0.08% 221
2023
Q4
$364M Buy
7,086,056
+401,783
+6% +$20.6M 0.05% 304
2023
Q3
$388M Buy
6,684,273
+554,532
+9% +$32.2M 0.06% 279
2023
Q2
$392M Sell
6,129,741
-878,078
-13% -$56.2M 0.05% 278
2023
Q1
$486M Sell
7,007,819
-389,635
-5% -$27M 0.07% 242
2022
Q4
$532M Buy
7,397,454
+1,311,960
+22% +$94.4M 0.09% 217
2022
Q3
$433M Sell
6,085,494
-8,501,529
-58% -$604M 0.07% 245
2022
Q2
$1.12B Sell
14,587,023
-1,216,245
-8% -$93.7M 0.14% 154
2022
Q1
$1.15B Buy
15,803,268
+12,445,264
+371% +$909M 0.12% 181
2021
Q4
$209M Sell
3,358,004
-541,195
-14% -$33.7M 0.02% 544
2021
Q3
$231M Buy
3,899,199
+325,660
+9% +$19.3M 0.02% 500
2021
Q2
$239M Sell
3,573,539
-55,905
-2% -$3.74M 0.02% 507
2021
Q1
$229M Sell
3,629,444
-305,655
-8% -$19.3M 0.02% 516
2020
Q4
$244M Sell
3,935,099
-2,942,142
-43% -$183M 0.03% 475
2020
Q3
$415M Sell
6,877,241
-1,766,224
-20% -$106M 0.05% 332
2020
Q2
$508M Sell
8,643,465
-1,051,375
-11% -$61.8M 0.06% 294
2020
Q1
$540M Sell
9,694,840
-1,468,911
-13% -$81.9M 0.09% 244
2019
Q4
$717M Sell
11,163,751
-2,321,008
-17% -$149M 0.09% 235
2019
Q3
$684M Buy
13,484,759
+735,214
+6% +$37.3M 0.1% 222
2019
Q2
$578M Buy
12,749,545
+3,816,247
+43% +$173M 0.08% 261
2019
Q1
$426M Buy
8,933,298
+991,653
+12% +$47.3M 0.06% 293
2018
Q4
$413M Sell
7,941,645
-3,232,970
-29% -$168M 0.07% 268
2018
Q3
$694M Buy
11,174,615
+565,258
+5% +$35.1M 0.1% 211
2018
Q2
$587M Sell
10,609,357
-258,159
-2% -$14.3M 0.09% 223
2018
Q1
$687M Sell
10,867,516
-1,342,479
-11% -$84.9M 0.11% 198
2017
Q4
$748M Sell
12,209,995
-708,211
-5% -$43.4M 0.12% 179
2017
Q3
$823M Sell
12,918,206
-560,835
-4% -$35.7M 0.14% 166
2017
Q2
$751M Sell
13,479,041
-10,079,650
-43% -$562M 0.14% 173
2017
Q1
$1.28B Sell
23,558,691
-13,458,040
-36% -$732M 0.24% 103
2016
Q4
$2.16B Sell
37,016,731
-8,123,043
-18% -$475M 0.43% 51
2016
Q3
$2.43B Sell
45,139,774
-27,116,075
-38% -$1.46B 0.49% 41
2016
Q2
$5.31B Buy
72,255,849
+7,001,439
+11% +$515M 1.13% 10
2016
Q1
$4.17B Buy
65,254,410
+16,444,038
+34% +$1.05B 0.89% 13
2015
Q4
$3.36B Buy
48,810,372
+6,881,745
+16% +$473M 0.71% 26
2015
Q3
$2.48B Buy
41,928,627
+8,426,181
+25% +$499M 0.55% 32
2015
Q2
$2.23B Buy
33,502,446
+19,098,742
+133% +$1.27B 0.46% 42
2015
Q1
$929M Sell
14,403,704
-794,738
-5% -$51.3M 0.19% 132
2014
Q4
$897M Sell
15,198,442
-261,710
-2% -$15.4M 0.19% 134
2014
Q3
$791M Sell
15,460,152
-1,284,302
-8% -$65.7M 0.17% 147
2014
Q2
$812M Sell
16,744,454
-909,460
-5% -$44.1M 0.18% 143
2014
Q1
$917M Buy
17,653,914
+2,796,015
+19% +$145M 0.21% 123
2013
Q4
$790M Buy
14,857,899
+733,510
+5% +$39M 0.18% 141
2013
Q3
$654M Buy
14,124,389
+12,730
+0.1% +$589K 0.16% 163
2013
Q2
$631M Buy
+14,111,659
New +$631M 0.17% 154